logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
C

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5
Papers295
Citations
Journal Papers 288
Publication Date
delete
Exclusion of Participants for Substance Use in Clinical Trials
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-07
delete0
PREAI
deleteWillyanne DeCormier Plosky; Benjamin C. Silverman; David H. Strauss; Barbara E. Bierer
deleteShare
deleteSave
Medication Use During Breastfeeding—An Understudied Population: A Five-Year Experience in the Pharmacovigilance Center of Lyon
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-07
delete0
deleteOAAI
deleteBlandine Bertin; Aurore Gouraud; Anthony Facile; Fanny Ledys; Sabrina Pierre; Véronique Pizzoglio; Thierry Vial; Marine Auffret; Marina Atzenhoffer
deleteShare
deleteSave
Dihydropyrimidine Dehydrogenase Genotype–Phenotype Correlations in Plasma and Peripheral Blood Mononuclear Cells
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-07
delete0
deleteOAAI
deleteBrianna M. Bembenek; Seid Hamzic; Kelly J. Bouchonville; Carlo R. Largiadèr; Steven M. Offer
deleteShare
deleteSave
Considerations for the Integration of Clinical Trials and Real-World Data
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-07
delete0
deleteOAAI
deleteSky Qiu; Charles E. Barr; Lauren Dang; Larry Han; Kajsa Kvist; Hana Lee; Andrew Mertens; Nerissa Nance; Lei Nie; Kara Rudolph; Xu Shi; Jens Tarp; Salina P. Waddy; Kenneth Wiley; Andy Wilson; Margot Lisa Jing Yann; Zhiwei Zhang; Tianyue Zhou; Maya Petersen; Mark van der Laan
deleteShare
deleteSave
Integrating Static and Dynamic Models to Predict Cannabidiol-Mediated Metabolic Drug–Drug Interactions
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-07
delete0
PREAI
deleteSulafa Al Sahlawi; Bassma Eltanameli; Brian Cicali; Rodrigo Cristofoletti
deleteShare
deleteSave
SGLT2 Inhibitors and Asthma Exacerbation Risk Among Patients With Type 2 Diabetes and Asthma: A Target Trial Emulation
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-07
delete0
PREAI
deleteKevin Yi-Chen Liao; Daniel Hsiang-Te Tsai; Michael Chun-Yuan Cheng; Han-Wei Mu; Kuan-Wen Su; Shih-Chieh Shao; Edward Chia-Cheng Lai
deleteShare
deleteSave
Acute Kidney Injury and Heart Failure Risk with Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitors: A Network Meta-Analysis
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-07
delete0
PREAI
deleteSatoru Mitsuboshi; Makoto Morizumi; Shungo Imai; Satoko Hori; Kazumasa Kotake
deleteShare
deleteSave
Evaluating Vaginal Microbiome Effects on Antiretroviral Exposure in the Female Genital Tract Using Pharmacometric and Machine Learning Approaches
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-03
delete0
deleteOAAI
deleteDiqin Yan; Lindsey B. Collins; Christopher Staley; Flavia Kiweewa Matovu; Pamala Jacobson; Melanie Nicol; Shen Cheng
deleteShare
deleteSave
Metformin Use Before Assisted Reproductive Technology and Pregnancy Outcomes in Women With Polycystic Ovary Syndrome: A Nationwide Cohort Study
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-03
delete0
PREAI
deleteYongtai Cho; Yeon Soo Park; Yubin Lee; HyunJoo Lim; Ju-Young Shin; Soo-Heon Kwak
deleteShare
deleteSave
Implementation of Rapid CYP2C19 Genotyping to Guide Antiplatelet Therapy for Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-02
delete0
PREAI
deleteD. Max Smith; Pamela Ramos Ramos; Shahrzad Ashena; Jacqueline Barnes; Anna Claire Barnett; Vandenia L. Barrow; Rut A. Beyene; Jennifer Broussard; Joeffrey Chahine; Sumeet Deogan; Rhajni A. Gooden; Elliot Dawson; Kelsey Dawson; Nicole Goff; Amie W. Hsia; Joel McAlduff; Karen Moriarty; Justin Reuter; Vinna Patricia San Juan; Sana Somani; Nicole P. Syed; Patricia C. Tsang; Ariel Woodward; Dimple J. Zaveri; Jay C. Zeck; Andrew Stemer; Sandra M. Swain
deleteShare
deleteSave
Measuring the Outcomes of International Oncology Regulatory Collaboration in Canada from 2019 to 2025: Project Orbis
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-02
delete0
deleteOAAI
deleteJonathan Zaslavsky; David C. Sealey
deleteShare
deleteSave
Pediatric Developmental Safety Assessment and New Approach Methodologies: US FDA/Triangle CERSI Workshop Report
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-02
delete0
deleteOAAI
deleteGilbert J. Burckart; Gelareh Abulwerdi; Christin L. Daniels; Calib Choi; Rebecca Racz; Jean-Pierre Valentin; Kristin Ardlie; Nicholas Tatonetti; Susan Laffan; Marjory Moreau; Will Redfern; Lang Li; James J. Hickman; Rajanikanth Madabushi; Bhagwat Prasad; Lynne Yao; Paul B. Watkins
deleteShare
deleteSave
Targeting Problems and Adhering to Standards: A Pathway to Uniform Clinical Laboratory Processes that Maximize the Benefits of Pharmacogenomics
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-10-01
delete0
PREAI
deleteElizabeth Fieg; Ben Kerman; Lucas A. Berenbrok; Samantha Frear; Lauren Marcath; Mylynda Massart; Natasha Berman
deleteShare
deleteSave
Multiscale Modeling of an 8-Week Combination Regimen of Bemnifosbuvir and Ruzasvir in Patients with Chronic Hepatitis C Virus Infection
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-09-30
delete0
deleteOAAI
deleteCarolin Zitzmann; Ruy M. Ribeiro; Aurelien Marc; Xiao-Jian Zhou; Alan S. Perelson
deleteShare
deleteSave
Advances in New Approach Methodologies at FDA's Division of Applied Regulatory Science
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-09-30
delete0
deleteOAAI
deleteKsenia Blinova; Kimberly Chiu; Anik Chaturbedi; Jahan Cooper; Tromondae K. Feaster; Paula L. Hyland; Lidiya Stavitskaya; Wendy W. Wu; Jeffry Florian; Rodney Rouse
deleteShare
deleteSave
The Hidden Cost of QTc Assessment: A Quantitative Weight of Evidence Framework to Eliminate Structural False Positives and Restore the Lost Opportunity Cost of Abandoned Medicines
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-09-30
delete0
PREAI
deleteMatthew M. Abernathy; Charles T. Benson; Derek J. Leishman
deleteShare
deleteSave
From Prediction to Decision Making: PBPK and QSP as Regulatory-Grade NAMs
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-09-30
delete0
deleteOAAI
deleteKaren Rowland Yeo; Piet H. van der Graaf
deleteShare
deleteSave
Trust, but Verify: Translating Dosing Evidence to Understudied Populations in Low- and Middle-Income Countries
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-09-30
delete0
deleteOAAI
deleteRoland van Rensburg; Veshni Pillay-Fuentes Lorente; Eric Decloedt
deleteShare
deleteSave
Model-Informed Dose Optimization of Anakinra in Preterm Neonates Implications for Safe and Effective Dosing
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-09-30
delete0
deleteOAAI
deleteJia Li; David K. Metz; Elys Green; Gergely Toldi; Robert Galinsky; Megan Clark; Rebecka Atkinson; Ina Rudloff; Josephine C. Owen; Sara K. DiSimone; Samuel C. Forster; Steven X. Cho; Atif Majid; Graeme R. Polglase; Marcel Favilla; Pramod Pharande; Atul Malhotra; Calum T. Roberts; Scott H. Stansfield; Arvind Sehgal; Kenneth Tan; Alistair J. Gunn; Philip J. Berger; Alex Veldman; Rod W. Hunt; Claudia A. Nold-Petry; Marcel F. Nold; Carl M. J. Kirkpatrick
deleteShare
deleteSave
Analysis of Suffix Use for Biosimilar Product Identification in Postmarketing Adverse Event Reporting
deleteCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
delete2026-09-30
delete0
deleteOAAI
deleteDanijela Stojanovic; Lisa Wolf; M. Stacey Ricci; Monica A. Muñoz
deleteShare
deleteSave